FMI estimates the global cold plasma market size to reach US$ 9380.9 million by 2033 growing from US$ 2164.7 million in 2022. Throughout the forecasted period of 2023 to 2033, the demand for cold plasma is anticipated to increase at a CAGR of 14.3%. Cold plasma has emerged as a novel non-thermal food processing technology utilizing reactive …
Author Archives: Editor AN
Acute Migraine Treatment Market is likely to register CAGR of 4.9% by 2032
The global acute migraine treatment market is expected to be worth US$ 8.6 billion in 2032, with a CAGR of 4.9% from 2022 to 2032. It is expected to reach US$ 2.4 billion by 2022. The rising prevalence of migraine due to the rapid adoption of unhealthy lifestyles is expected to increase demand for acute migraine treatment options …
Continue reading “Acute Migraine Treatment Market is likely to register CAGR of 4.9% by 2032”
Pediatric Clinical Trials Market is expected to gain a size of US$ 26.47 Billion by 2032
During the forecast period 2022 to 2032, the global pediatric clinical trials market is expected to grow at a value of 5.3%, according to Future Market Insights. In 2021, this market was predicted to have a global valuation of US$ 15 Billion, and is expected to reach a sum of US$ 26.47 Billion by 2032. The market is going to face increasing …
Blood Banking Equipment Market is projected to reach US$ 23.4 Billion by 2032, at a CAGR 4.7%
According to Future Market Insights, the global blood banking equipment market held a valuation of about US$ 14.8 Billion in 2022. As per the study, sales are expected to increase at a CAGR of 4.7% during the forecast period (2022 to 2032), surpassing US$ 23.4 Billion in 2032. The rising number of surgical procedures and accidents has created a growing need for blood components, …
Lung Cancer to Procure 35% Oncolytic Adenovirus Market | FMI Study
During the forecast period 2023 to 2033, the oncolytic adenovirus market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for oncolytic adenovirus is expected to rise up to a market valuation of US$ 250 Billion. Growth of the market can be …
Continue reading “Lung Cancer to Procure 35% Oncolytic Adenovirus Market | FMI Study”
According to Future Market Insights, the non-surgical segment by treatment type is predicted to acquire more than 50% global exophthalmos treatment market share in 2023.
In fiscal year 2023, the market for exophthalmos treatment is anticipated to be valued US$ 271.8 million, up from US$ 251.2 million in fiscal year 2022. The worldwide market is anticipated to increase steadily between 2023 and 2033, increasing its value to US$ 598 million by the end of that year. Graves’ illness is most …
Surgical Treatment to Possess 60% Market Share for Chiari Malformation Treatment Market | FMI Study
During the forecast period 2023 to 2033, the Chiari malformation treatment market is expected to grow at a value of 6.4% CAGR, according to Future Market Insights. By the year 2033, the global market for Chiari malformation treatment is expected to rise up to a market valuation of US$ 4.2 Billion. Growth of the market …
Small-scale Bioreactors Market size is estimated to stand at US$ 7.71 billion by 2033
The global small-scale bioreactors market is predicted to register a CAGR of 14.8% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 1.94 billion in 2023 to US$ 7.71 billion by 2033 end. New therapies are expected to be increasingly developed in the coming years due to …
How Microbial Fermentation Technology is Transforming the Biosimilars Industry? FMI Predicts the Market to Surpass US$ 56.9 billion by 2033
The global microbial fermentation technology market is expected to reach a value of US$ 32,729.05 million in 2023. The market is projected to grow at a CAGR of 5.7% and exceeds US$ 56,974.87 million by 2033. The microbial fermentation technology industry has been experiencing significant growth in recent years, with a growing demand for biopharmaceutical …
Healthcare Manufacturers Develop Gabapentin Tablets to Treat Patients Nerve Pain, Seizures, and Related Disorders. Know More Trends with FMI
The gabapentin market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period. How are Manufacturers Developing Suitable Gabapentin Products for Patients? Gabapentin is a medication used to treat seizures, neuropathic pain, and restless leg …